<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Caspase-11 cleaves gasdermin D for non-canonical inflammasome signalling</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><forename type="first">Nobuhiko</forename><surname>Kayagaki</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Physiological Chemistry</orgName>
								<orgName type="institution">Genentech Inc</orgName>
								<address>
									<postCode>94080</postCode>
									<settlement>South San Francisco</settlement>
									<region>California</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Irma</forename><forename type="middle">B</forename><surname>Stowe</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Physiological Chemistry</orgName>
								<orgName type="institution">Genentech Inc</orgName>
								<address>
									<postCode>94080</postCode>
									<settlement>South San Francisco</settlement>
									<region>California</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Bettina</forename><forename type="middle">L</forename><surname>Lee</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Physiological Chemistry</orgName>
								<orgName type="institution">Genentech Inc</orgName>
								<address>
									<postCode>94080</postCode>
									<settlement>South San Francisco</settlement>
									<region>California</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Karen</forename><surname>O'rourke</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Physiological Chemistry</orgName>
								<orgName type="institution">Genentech Inc</orgName>
								<address>
									<postCode>94080</postCode>
									<settlement>South San Francisco</settlement>
									<region>California</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Keith</forename><surname>Anderson</surname></persName>
							<affiliation key="aff1">
								<orgName type="department">Department of Molecular Biology</orgName>
								<orgName type="institution">Genentech Inc</orgName>
								<address>
									<postCode>94080</postCode>
									<settlement>South San Francisco</settlement>
									<region>California</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">SÃ¸ren</forename><surname>Warming</surname></persName>
							<affiliation key="aff1">
								<orgName type="department">Department of Molecular Biology</orgName>
								<orgName type="institution">Genentech Inc</orgName>
								<address>
									<postCode>94080</postCode>
									<settlement>South San Francisco</settlement>
									<region>California</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Trinna</forename><surname>Cuellar</surname></persName>
							<affiliation key="aff1">
								<orgName type="department">Department of Molecular Biology</orgName>
								<orgName type="institution">Genentech Inc</orgName>
								<address>
									<postCode>94080</postCode>
									<settlement>South San Francisco</settlement>
									<region>California</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Benjamin</forename><surname>Haley</surname></persName>
							<affiliation key="aff1">
								<orgName type="department">Department of Molecular Biology</orgName>
								<orgName type="institution">Genentech Inc</orgName>
								<address>
									<postCode>94080</postCode>
									<settlement>South San Francisco</settlement>
									<region>California</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Merone</forename><surname>Roose-Girma</surname></persName>
							<affiliation key="aff1">
								<orgName type="department">Department of Molecular Biology</orgName>
								<orgName type="institution">Genentech Inc</orgName>
								<address>
									<postCode>94080</postCode>
									<settlement>South San Francisco</settlement>
									<region>California</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Qui</forename><forename type="middle">T</forename><surname>Phung</surname></persName>
							<affiliation key="aff2">
								<orgName type="department">Department of Protein Chemistry</orgName>
								<orgName type="institution">Genentech Inc</orgName>
								<address>
									<postCode>94080</postCode>
									<settlement>South San Francisco</settlement>
									<region>California</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Peter</forename><forename type="middle">S</forename><surname>Liu</surname></persName>
							<affiliation key="aff2">
								<orgName type="department">Department of Protein Chemistry</orgName>
								<orgName type="institution">Genentech Inc</orgName>
								<address>
									<postCode>94080</postCode>
									<settlement>South San Francisco</settlement>
									<region>California</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Jennie</forename><forename type="middle">R</forename><surname>Lill</surname></persName>
							<affiliation key="aff2">
								<orgName type="department">Department of Protein Chemistry</orgName>
								<orgName type="institution">Genentech Inc</orgName>
								<address>
									<postCode>94080</postCode>
									<settlement>South San Francisco</settlement>
									<region>California</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Hong</forename><surname>Li</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Jiansheng</forename><surname>Wu</surname></persName>
							<affiliation key="aff2">
								<orgName type="department">Department of Protein Chemistry</orgName>
								<orgName type="institution">Genentech Inc</orgName>
								<address>
									<postCode>94080</postCode>
									<settlement>South San Francisco</settlement>
									<region>California</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Sarah</forename><surname>Kummerfeld</surname></persName>
							<affiliation key="aff2">
								<orgName type="department">Department of Protein Chemistry</orgName>
								<orgName type="institution">Genentech Inc</orgName>
								<address>
									<postCode>94080</postCode>
									<settlement>South San Francisco</settlement>
									<region>California</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
							<affiliation key="aff3">
								<orgName type="department">Department of Bioinformatics</orgName>
								<orgName type="institution">Genentech Inc</orgName>
								<address>
									<postCode>94080</postCode>
									<settlement>South San Francisco</settlement>
									<region>California</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Juan</forename><surname>Zhang</surname></persName>
							<affiliation key="aff4">
								<orgName type="department">Department of Immunology</orgName>
								<orgName type="institution">Genentech Inc</orgName>
								<address>
									<postCode>94080</postCode>
									<settlement>South San Francisco</settlement>
									<region>California</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Wyne</forename><forename type="middle">P</forename><surname>Lee</surname></persName>
							<affiliation key="aff4">
								<orgName type="department">Department of Immunology</orgName>
								<orgName type="institution">Genentech Inc</orgName>
								<address>
									<postCode>94080</postCode>
									<settlement>South San Francisco</settlement>
									<region>California</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Scott</forename><forename type="middle">J</forename><surname>Snipas</surname></persName>
							<affiliation key="aff5">
								<orgName type="department">Program in Cell Death Signaling Networks</orgName>
								<orgName type="institution">Sanford-Burnham-Prebys Medical Discovery Institute</orgName>
								<address>
									<addrLine>La Jolla</addrLine>
									<postCode>92037</postCode>
									<region>California</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Guy</forename><forename type="middle">S</forename><surname>Salvesen</surname></persName>
							<affiliation key="aff5">
								<orgName type="department">Program in Cell Death Signaling Networks</orgName>
								<orgName type="institution">Sanford-Burnham-Prebys Medical Discovery Institute</orgName>
								<address>
									<addrLine>La Jolla</addrLine>
									<postCode>92037</postCode>
									<region>California</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Lucy</forename><forename type="middle">X</forename><surname>Morris</surname></persName>
							<affiliation key="aff6">
								<orgName type="department" key="dep1">The Australian Phenomics Facility</orgName>
								<orgName type="department" key="dep2">The John Curtin School of Medical Research</orgName>
								<orgName type="institution">The Australian National University</orgName>
								<address>
									<postCode>2601</postCode>
									<settlement>Canberra</settlement>
									<region>Australian Capital Territory</region>
									<country key="AU">Australia</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Linda</forename><surname>Fitzgerald</surname></persName>
							<affiliation key="aff6">
								<orgName type="department" key="dep1">The Australian Phenomics Facility</orgName>
								<orgName type="department" key="dep2">The John Curtin School of Medical Research</orgName>
								<orgName type="institution">The Australian National University</orgName>
								<address>
									<postCode>2601</postCode>
									<settlement>Canberra</settlement>
									<region>Australian Capital Territory</region>
									<country key="AU">Australia</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Yafei</forename><surname>Zhang</surname></persName>
							<affiliation key="aff6">
								<orgName type="department" key="dep1">The Australian Phenomics Facility</orgName>
								<orgName type="department" key="dep2">The John Curtin School of Medical Research</orgName>
								<orgName type="institution">The Australian National University</orgName>
								<address>
									<postCode>2601</postCode>
									<settlement>Canberra</settlement>
									<region>Australian Capital Territory</region>
									<country key="AU">Australia</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Edward</forename><forename type="middle">M</forename><surname>Bertram</surname></persName>
							<affiliation key="aff6">
								<orgName type="department" key="dep1">The Australian Phenomics Facility</orgName>
								<orgName type="department" key="dep2">The John Curtin School of Medical Research</orgName>
								<orgName type="institution">The Australian National University</orgName>
								<address>
									<postCode>2601</postCode>
									<settlement>Canberra</settlement>
									<region>Australian Capital Territory</region>
									<country key="AU">Australia</country>
								</address>
							</affiliation>
							<affiliation key="aff7">
								<orgName type="department">Department of Immunology and Infectious Diseases</orgName>
								<orgName type="institution" key="instit1">The John Curtin School of Medical Research</orgName>
								<orgName type="institution" key="instit2">The Australian National University</orgName>
								<address>
									<postCode>2601</postCode>
									<settlement>Canberra</settlement>
									<region>Australian Capital Territory</region>
									<country key="AU">Australia</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Christopher</forename><forename type="middle">C</forename><surname>Goodnow</surname></persName>
							<affiliation key="aff7">
								<orgName type="department">Department of Immunology and Infectious Diseases</orgName>
								<orgName type="institution" key="instit1">The John Curtin School of Medical Research</orgName>
								<orgName type="institution" key="instit2">The Australian National University</orgName>
								<address>
									<postCode>2601</postCode>
									<settlement>Canberra</settlement>
									<region>Australian Capital Territory</region>
									<country key="AU">Australia</country>
								</address>
							</affiliation>
							<affiliation key="aff8">
								<orgName type="institution">Garvan Institute of Medical Research</orgName>
								<address>
									<postCode>2010</postCode>
									<settlement>Sydney</settlement>
									<region>New South Wales</region>
									<country key="AU">Australia</country>
								</address>
							</affiliation>
							<affiliation key="aff9">
								<orgName type="department">St. Vincent&apos;s Clinical School</orgName>
								<orgName type="institution">UNSW Australia</orgName>
								<address>
									<postCode>2010</postCode>
									<settlement>Darlinghurst</settlement>
									<region>New South Wales</region>
									<country key="AU">Australia</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Vishva</forename><forename type="middle">M</forename><surname>Dixit</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Physiological Chemistry</orgName>
								<orgName type="institution">Genentech Inc</orgName>
								<address>
									<postCode>94080</postCode>
									<settlement>South San Francisco</settlement>
									<region>California</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">Caspase-11 cleaves gasdermin D for non-canonical inflammasome signalling</title>
					</analytic>
					<monogr>
						<imprint>
							<date/>
						</imprint>
					</monogr>
					<idno type="MD5">4740CB396F4293D404FC5B756146AE47</idno>
					<idno type="DOI">10.1038/nature15541</idno>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.8.2-SNAPSHOT" ident="GROBID" when="2025-03-14T13:55+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<abstract/>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><p>Intracellular lipopolysaccharide from Gram-negative bacteria including Escherichia coli, Salmonella typhimurium, Shigella flexneri, and Burkholderia thailandensis activates mouse caspase-11, causing pyroptotic cell death, interleukin-1b processing, and lethal septic shock. How caspase-11 executes these downstream signalling events is largely unknown. Here we show that gasdermin D is essential for caspase-11-dependent pyroptosis and interleukin-1b maturation. A forward genetic screen with ethyl-N-nitrosourea-mutagenized mice links Gsdmd to the intracellular lipopolysaccharide response. Macrophages from Gsdmd 2/2 mice generated by gene targeting also exhibit defective pyroptosis and interleukin-1b secretion induced by cytoplasmic lipopolysaccharide or Gram-negative bacteria. In addition, Gsdmd 2/2 mice are protected from a lethal dose of lipopolysaccharide. Mechanistically, caspase-11 cleaves gasdermin D, and the resulting amino-terminal fragment promotes both pyroptosis and NLRP3-dependent activation of caspase-1 in a cell-intrinsic manner. Our data identify gasdermin D as a critical target of caspase-11 and a key mediator of the host response against Gram-negative bacteria.</p><p>Cytoplasmic caspase-11 (also known as caspase-4) defines the noncanonical inflammasome that is activated by various Gram-negative bacterial infections and causes infected cells to die by pyroptosis <ref type="bibr">[1]</ref><ref type="bibr">[2]</ref><ref type="bibr">[3]</ref><ref type="bibr">[4]</ref> . Caspase-11 also triggers NLRP3-and ASC-dependent activation of caspase-1, resulting in the proteolytic maturation of the inactive cytokine pro-interleukin (IL)-1b (refs 1, 5-7). Lipopolysaccharide (LPS) is the bacterial pathogen-associated molecular pattern that promotes caspase-11 activation <ref type="bibr" target="#b0">7,</ref><ref type="bibr" target="#b1">8</ref> . Cytoplasmic LPS can directly bind to and activate caspase-11 independently of Toll-like receptor 4 (TLR4) <ref type="bibr" target="#b2">9</ref> , but precisely how caspase-11 executes pyroptosis and non-canonical NLRP3 inflammasome activation has remained unknown.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Phenomics identifies gasdermin D</head><p>An unbiased forward genetic screen with ethyl-N-nitrosourea (ENU)mutagenized mice <ref type="bibr" target="#b3">10</ref> was performed to unveil essential mediators of noncanonical inflammasome signalling in response to cytoplasmic LPS. Pedigree IGL1351 had a Mendelian recessive mutation that compromised LPS-induced IL-1b secretion from peritoneal macrophages. The severity of the defect was equivalent to that seen with the Casp11 mutant 129 strain 1 (Fig. <ref type="figure" target="#fig_0">1a</ref> and Extended Data Fig. <ref type="figure" target="#fig_0">1</ref>). Importantly, IL-1b secretion by pedigree IGL1351 in response to Clostridium difficile toxin B (TcdB), a stimulant of the Mediterranean fever/Pyrin canonical inflammasome <ref type="bibr">1,</ref><ref type="bibr" target="#b4">11</ref> , was comparable to other pedigrees. Exome sequencing identified 39 single-nucleotide variants (SNVs) in the ENU-mutated founder G1 male. Subsequent genotyping of all identified SNVs in a large cohort of siblings and offspring revealed that the trait was completely correlated with inheritance of a point mutation in the gene encoding gasdermin D (Gsdmd) (Extended Data Fig. <ref type="figure" target="#fig_0">1</ref> and Extended Data Table <ref type="table">1</ref>).</p><p>Gsdmd (ref. 12) is a 487 amino acid cytoplasmic protein that contains an ill-characterized gasdermin domain and lacks any obvious signal peptide or transmembrane segments (Fig. <ref type="figure" target="#fig_0">1b</ref>). The human gasdermin gene family consists of GSDMA, GSDMB, GSDMC and GSDMD. The physiological role of Gsdmd is unknown <ref type="bibr" target="#b6">13</ref> , although other gasdermin family members have been implicated in deafness or apoptosis in epithelial cells <ref type="bibr" target="#b5">12,</ref><ref type="bibr" target="#b7">14</ref> . The ENU-derived mutation in Gsdmd caused an Ile to Asn amino acid substitution at position 105 with a Polyphen score of 0.98 (probably damaging) and a SIFT (sorting intolerant from tolerant) score of 0.00 (deleterious) (Fig. <ref type="figure" target="#fig_0">1b</ref> and Extended Data Table <ref type="table">1</ref>). Full-length Gsdmd protein (53 kDa) was immunoblotted in unstimulated wild-type bone-marrow-derived macrophages (BMDMs). Unlike pro-caspase-11, Gsdmd was not induced to any great extent by TLR agonists or interferons (Fig. <ref type="figure" target="#fig_0">1c</ref>). Wild-type and Gsdmd I105N/I105N BMDMs expressed comparable amounts of Gsdmd (Fig. <ref type="figure" target="#fig_0">1d</ref>), suggesting that the I105N mutation impairs Gsdmd function rather than protein expression.</p><p>Wild-type, Casp11 2/2 , or Gsdmd I105N/I105N BMDMs that were primed with Pam3CSK4 and then stimulated with canonical inflammasome stimuli, including ATP to engage the NLRP3-dependent inflammasome 6 , poly(dA:dT) double-stranded DNA (dsDNA) to activate the AIM2-dependent inflammasome <ref type="bibr" target="#b8">[15]</ref><ref type="bibr" target="#b9">[16]</ref><ref type="bibr" target="#b10">[17]</ref> , or TcdB <ref type="bibr" target="#b4">11</ref> , secreted comparable amounts of IL-1b and exhibited similar levels of pyroptotic death 1 (Fig. <ref type="figure" target="#fig_0">1e</ref>). Consistent with these data, Gsdmd I105N/I105N BMDMs displayed normal induction of NLRP3, pro-IL-1b, and RANTES cytokine in response to TLR agonists (Fig. <ref type="figure" target="#fig_0">1d</ref>, Extended Data Fig. <ref type="figure" target="#fig_2">2a</ref>). Gsdmd I105N/I105N BMDMs also upregulated procaspase-11 normally (Fig. <ref type="figure" target="#fig_0">1d</ref>) but, in contrast to their wild-type counterparts, were defective in IL-1b secretion, and did not undergo pyroptosis in response to cytoplasmic LPS (Fig. <ref type="figure" target="#fig_0">1e</ref>). Proteolytic processing of caspase-1 and pro-IL-1b preceding IL-1b secretion was also impaired, suggesting that Gsdmd is critical for all caspase-11dependent signalling events (Extended Data Fig. <ref type="figure" target="#fig_2">2b</ref>).</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Gsdmd is essential for caspase-11 signalling</head><p>We confirmed a critical role for Gsdmd in non-canonical inflammasome signalling using gene-targeted Gsdmd 2/2 mice. In control experiments, Pam3CSK4-primed wild-type, Gsdmd 2/2 , and Casp11 2/2 BMDMs exhibited equivalent caspase-1-dependent IL-1b secretion and pyroptosis after a 16 h treatment with TcdB, ATP, dsDNA, or the NLRC4 inflammasome trigger flagellin <ref type="bibr" target="#b11">18</ref> (Fig. <ref type="figure" target="#fig_2">2a</ref> and Extended Data Fig. <ref type="figure">3a,</ref><ref type="figure">b</ref>). The effect of Gsdmd deficiency on caspase-1-dependent pyroptosis at earlier time points is discussed in a later section. Caspase-11 or Gsdmd deficiency also had no effect on IL-1b secretion in response to other canonical NLRP3 inflammasome stimuli including listeriolysin O (LLO) toxin, monosodium urate (MSU), lysomotropic agent HLLOMe, or calcium pyrophosphate (CPPD) 1, <ref type="bibr" target="#b12">[19]</ref><ref type="bibr" target="#b13">[20]</ref><ref type="bibr" target="#b14">[21]</ref><ref type="bibr" target="#b15">[22]</ref> (Extended Data Fig. <ref type="figure">3c,</ref><ref type="figure">d</ref>). In keeping with these data, TLR agonists induced NLRP3, pro-caspase-11, and RANTES to a similar extent in wild-type and Gsdmd 2/2 BMDMs (Extended Data Fig. <ref type="figure">3a,</ref><ref type="figure">e</ref>). Therefore, Gsdmd is dispensable for normal TLR priming. Gsdmd 2/2 BMDMs were, however, resistant to pyroptosis and failed to secrete IL-1b when transfected with E. coli LPS or synthetic monophosphoryl lipid A, the active moiety of LPS <ref type="bibr" target="#b0">7,</ref><ref type="bibr" target="#b1">8</ref> (Fig. <ref type="figure" target="#fig_2">2a</ref>, Extended Data Fig. <ref type="figure">3b</ref>). Gsdmd 2/2 BMDMs were also unresponsive to electroporated LPS, or LPS transfected with cholera toxin B complex <ref type="bibr" target="#b0">7</ref> , or S. typhimurium LPS (Extended Data Fig. <ref type="figure">3f</ref>). Gsdmd, like Casp11, was also required for processing of pro-caspase-1 and pro-IL-1b in response to cytoplasmic LPS (Fig. <ref type="figure" target="#fig_2">2b</ref>). Finally, Gsdmd 2/2 BMDMs further resembled Casp11 2/2 BMDMs in failing to secrete IL-1b or undergo pyroptosis upon infection with Gram-negative bacteria (E. coli, Citrobacter rodentium, or Shigella flexneri), whereas both genotypes responded normally to Pseudomonas aeruginosa that activates the NLRC4 canonical inflammasome 1,3,7,23 (Fig. <ref type="figure" target="#fig_2">2c</ref>). Collectively, these data confirm that macrophages require Gsdmd for pyroptosis and IL-1b secretion in response to intracellular LPS.</p><p>Human caspase-4 and caspase-5, the orthologues of mouse caspase-11, induce pyroptosis in myeloid and endothelial cells in response to intracellular LPS <ref type="bibr" target="#b2">9,</ref><ref type="bibr" target="#b17">24</ref> . Like caspase-4/5/11, Gsdmd is specific to mammals <ref type="bibr" target="#b7">14,</ref><ref type="bibr" target="#b18">25</ref> , suggesting a co-emergence of those genes. Human GSDMD exhibits 58% amino acid sequence identity with mouse Gsdmd. Deletion of GSDMD or CASP4 by CRISPR/Cas9 in human EA.hy926 endothelial cells or human THP-1 monocytes did not affect death induced by APO2L <ref type="bibr" target="#b19">26</ref> or dsDNA, but it completely abolished intracellular LPS-induced cytotoxicity (Fig. <ref type="figure" target="#fig_2">2d</ref>, Extended Data Fig. <ref type="figure">3g-i</ref>). Thus, human GSDMD is required for the caspase-4-dependent response to cytoplasmic LPS.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Caspase-11 cleaves and activates Gsdmd</head><p>We next questioned how Gsdmd promotes pyroptosis and caspase-1 activation by the non-canonical inflammasome. We noticed that BMDMs transfected with LPS exhibited caspase-11-dependent cleavage of Gsdmd, giving rise to a 30-kDa N-terminal Gsdmd fragment (Fig. <ref type="figure">3a</ref>). These data identified Gsdmd as a potential substrate of caspase-11. Recombinant caspase-11 cleaves artificial peptide substrates after an aspartate residue <ref type="bibr" target="#b20">27,</ref><ref type="bibr" target="#b21">28</ref> , but physiological substrates of caspase-11 are not well defined. Purified recombinant Gsdmd was cleaved by recombinant caspase-11 in vitro into two fragments. Edman sequencing mapped the cleavage site in Gsdmd to LLSD 276 #G 277 (Fig. <ref type="figure">3b</ref>). The P 1 -Asp cleavage residue and P 1 9-Gly residues are conserved across species (Extended Data Fig. <ref type="figure">4a</ref>). Ectopic expression of the N-terminal Gsdmd cleavage fragment (mouse residues 1-276) killed HEK293T cells, whereas expression of full-length Gsdmd or the C-terminal cleavage fragment did not (Fig. <ref type="figure">3c</ref>). Collectively, these data indicate that caspase-11 directly cleaves the 53-kDa inactive precursor form of Gsdmd (pro-Gsdmd) to generate the propyroptotic N-terminal fragment (Gsdmd p30, Fig. <ref type="figure" target="#fig_0">1b</ref>). In full-length Gsdmd, the C terminus may mask key sites in the N terminus until cleavage at D 276 #G 277 releases this inhibition. Consistent with this notion, reconstitution of immortalized Gsdmd 2/2 macrophages with wild-type Gsdmd restored LPS responsiveness, as evidenced by lactate dehydrogenase (LDH) release, IL-1b secretion and caspase-1 processing, whereas reconstitution with the Gsdmd processing mutant D276A did not (Fig. <ref type="figure">3d,</ref><ref type="figure">e</ref>). In addition, mutation of Gsdmd within the p30 fragment (I105N) attenuated pyroptosis and caspase-1/IL-1b processing (Fig. <ref type="figure" target="#fig_0">1b</ref>, e and Extended Data Fig. <ref type="figure" target="#fig_2">2b</ref>) without affecting Gsdmd cleavage (Extended Data Fig. <ref type="figure">4b</ref>). These data confirm that conversion of pro-Gsdmd to its mature p30 form by caspase-11 is essential for both pyroptosis and caspase-1 activation in response to cytoplasmic LPS. Cytoplasmic LPS also caused caspase-4-dependent processing of GSDMD in human THP-1 monocytes (Extended Data Fig. <ref type="figure">5a</ref>). Furthermore, transient overexpression of caspase-4 or caspase-5 caused human GSDMD cleavage to the pro-pyroptotic p30 fragment (Extended Data Fig. <ref type="figure">5b</ref> and<ref type="figure">c</ref>). These data together with the conserved P 1 and P 1 9 residues in GSDMD (Extended Data Fig. <ref type="figure">4a</ref>) indicate a conserved mechanism of GSDMD activation by caspase-4/5/11.</p><p>Cytoplasmic LPS induces caspase-11-dependent pyroptosis and secretion of IL-1b, but only the latter requires caspase-1, NLRP3 and ASC 1,7 . Loss of NLRP3, ASC, or caspase-1 in BMDMs did not markedly affect caspase-11-dependent generation of mature Gsdmd p30 in response to cytoplasmic LPS (Fig. <ref type="figure">4a</ref>), indicating that Gsdmd cleavage occurs upstream of NLRP3 inflammasome activation. The question arises as to whether Gsdmd induces pyroptosis and NLRP3 inflammasome activation simultaneously in the same cell, or if Gsdmd-mediated pyroptosis releases damage-associated molecular patterns <ref type="bibr" target="#b22">29</ref> that trigger caspase-11-independent NLRP3 inflammasome activation in neighbouring cells (Extended Data Fig. <ref type="figure">6a</ref>). We believe the latter hypothesis is unlikely because LPS-stimulated Il1b 2/2 BMDMs exhibited normal pyroptosis, yet their culture supernatant failed to induce IL-1b secretion from Casp11 2/2 BMDMs (Extended Data Fig. <ref type="figure">6b,</ref><ref type="figure">c</ref>). In addition, Casp11 2/2 BMDMs co-cultured with Il1b 2/2 BMDMs did not secrete IL-1b in response to cytoplasmic LPS (Fig. <ref type="figure">4b</ref> and Extended Data Fig. <ref type="figure">6d</ref>), making it unlikely that a paracrine signalling mechanism activates the NLRP3 inflammasome <ref type="bibr" target="#b23">30</ref> . Collectively, our data demonstrate that Gsdmd maturation by caspase-11 triggers two distinct cell-intrinsic signals: Pam3CSK4 priming (i) pyroptosis induction; and (ii) NLRP3-dependent caspase-1 activation (Fig. <ref type="figure">4c</ref>).</p><formula xml:id="formula_0">Gsdmd -/-2 WT Casp11 -/- Gsdmd -/-1 Gsdmd -/-2 WT Casp11 -/- Gsdmd -/-1 G s d m d -/ -2 W T C a s p 1 1 -/ - G s d m d -/ -1 G s d m d -/ -2 W T C a s p 1 1 -/ - G s d m d -/ -</formula></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Role for Gsdmd in canonical pyroptosis</head><p>Human caspase-1 is reported to cleave GSDMD at the same P 1 -Asp residue <ref type="bibr" target="#b24">31</ref> as caspase-11, albeit that the preferred tetrapeptide cleavage sequence of caspase-1 differs from that of caspase-11 <ref type="bibr" target="#b20">27,</ref><ref type="bibr" target="#b21">28</ref> . Consistent with this study <ref type="bibr" target="#b24">31</ref> , the Gsdmd p30 fragment appeared in BMDMs treated with canonical inflammasome activators including ATP (Fig. <ref type="figure">5a</ref> and Extended Data Fig. <ref type="figure">7a</ref>). Although Gsdmd 2/2 BMDMs stimulated with ATP or flagellin underwent pyroptosis normally after 8 h, they exhibited less pyroptosis than wild-type BMDMs at earlier time points (Figs 2a and 5c and Extended Data Fig. <ref type="figure">7b</ref>). These data suggest that Gsdmd is also a physiological substrate of caspase-1. However, given that caspase-1-dependent pyroptosis is delayed rather than prevented, we believe that other ill-defined caspase-1 substrates can also mediate pyroptosis (Fig. <ref type="figure">5d</ref>). This notion is in keeping with the fact that caspase-1 orthologues are found in vertebrates including non-mammals, whereas caspase-4/5/11 and Gsdmd are exclusive to mammals <ref type="bibr" target="#b7">14,</ref><ref type="bibr" target="#b18">25,</ref><ref type="bibr" target="#b25">32</ref> . Consistent with IL-1b being a direct substrate of caspase-1 33 , Gsdmd deficiency did not impact caspase-1-dependent IL-1b processing in response to ATP (Fig. <ref type="figure">5b</ref>). However, Gsdmd 2/2 BMDMs secreted less IL-1b than wild-type at the 2-h time points in response to ATP and flagellin (Extended Data Fig. <ref type="figure">7c</ref>). Gsdmd may contribute to IL-1b release by damaging cell membranes or regulating the ill-characterized IL-1b secretion mechanism <ref type="bibr" target="#b27">34,</ref><ref type="bibr" target="#b28">35</ref> .</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Gsdmd is essential for lethal sepsis</head><p>We investigated the relevance of our in vitro findings in a mouse model of acute septic shock wherein caspase-11-dependent pyroptosis leads to lethal endotoxemia <ref type="bibr">1,</ref><ref type="bibr" target="#b29">36</ref> . Mice lacking either Casp11 or Gsdmd were resistant to LPS-induced lethal septic shock (Fig. <ref type="figure">6</ref> and Extended Data Table <ref type="table">2</ref>). This result is consistent with Gsdmd being a critical pro-pyroptotic substrate of caspase-11 in vivo.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Discussion</head><p>Pyroptosis plays an important role in anti-bacterial innate immune defence and lethal endotoxemia 1, <ref type="bibr" target="#b30">37,</ref><ref type="bibr" target="#b31">38</ref> , but how inflammatory caspases 1, 4, 5 and 11 cause pyroptosis has remained unknown. Our data reveal that proteolytic cleavage of Gsdmd by mouse caspase-11 or human caspase-4 is essential for pyroptosis of innate immune cells and endothelial cells harbouring LPS-tainted cytoplasm. Cleaved Gsdmd also triggers NLRP3-dependent activation of caspase-1 through a cell-intrinsic pathway (Fig. <ref type="figure">4c</ref>), although the exact mechanism responsible for NLRP3 activation remains unclear. NLRP3 senses diverse stimuli that perturb intracellular homeostasis 6, <ref type="bibr" target="#b12">19,</ref><ref type="bibr" target="#b14">21,</ref><ref type="bibr" target="#b15">22</ref> , so its activation may be an indirect consequence of the effects of the Gsdmd p30 fragment. Future studies will need to address exactly what the p30 fragment does in cells. The redefined non-canonical inflammasome signalling pathway (Fig. <ref type="figure">4c</ref>) refutes the previous hypothesis that a caspase-1/11 complex is responsible for caspase-1 activation 1, <ref type="bibr" target="#b29">36</ref> .</p><p>The partial contribution of Gsdmd to caspase-1-dependent pyroptosis suggests the existence of other pro-pyroptotic caspase-1 substrates (Fig. <ref type="figure">5d</ref>). Caspase-1 can trigger pyroptosis in the absence of Gsdmd, which is not unexpected because non-mammalian vertebrates lack Gsdmd yet still exhibit caspase-1-dependent pyroptosis <ref type="bibr" target="#b7">14,</ref><ref type="bibr" target="#b18">25,</ref><ref type="bibr" target="#b25">32,</ref><ref type="bibr" target="#b32">39</ref> . The co-emergence of caspase-4/5/11 and Gsdmd genes in the early stages of mammalian evolution might indicate co-evolution, perhaps in response to the need for additional anti-pathogen responses against Gram-negative bacteria.</p><p>Like other caspases, caspase-11 cleaves multiple substrates <ref type="bibr" target="#b21">28,</ref><ref type="bibr" target="#b24">31,</ref><ref type="bibr" target="#b33">40</ref> . However, our in vitro and in vivo data show that caspase-11 relies exclusively on Gsdmd to promote pyroptosis, caspase-1 activation and LPS-induced lethal sepsis. Thus Gsdmd is revealed as an unexpected, but critical facet of the anti-bacterial response.</p><p>Online Content Methods, along with any additional Extended Data display items and Source Data, are available in the online version of the paper; references unique to these sections appear only in the online paper.  LPS. Gsdmd 2/2 6-13 mice were used (described in Extended Data Fig. <ref type="figure">8</ref>). Statistical analysis and P values (Extended Data Table <ref type="table">2</ref>) were adjusted to account for multiple comparisons using Bonferroni's correction.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>METHODS</head><p>ENU-mutagenized mouse strains. Third-generation (G3) offspring used for the phenotypic screen were from ENU-treated C57BL/6 mice as described <ref type="bibr" target="#b3">10</ref> . 129X1/ SvJ strain was used as a Casp11 mutant 1 control. All animals were housed under specific-pathogen-free conditions at the Australian Phenomics Facility. Animal experiments were approved by the Australian National University Animal Ethics and Experimentation Committee.</p><p>Exome capture and sequencing of G1 founder. Exome-enriched, paired-end libraries were prepared from genomic DNA of first generation (G1) mice using the Agilent SureSelect XT2 Mouse All Exon kit (Agilent) following the manufacturer's instructions. Each sample was prepared with an index and then pooled in a batch of six in equimolar amounts before exome enrichment. Each 6-plex exomeenriched library was sequenced in one lane of an Illumina HiSeq2000 with version 2 chemistry as 100-bp paired-end reads. ENU variants were identified as described previously <ref type="bibr" target="#b34">41</ref> . In brief, sequence reads were mapped to the GRCm38 assembly of the reference mouse genome using the default parameters of the Burrows-Wheeler Aligner (BWA, <ref type="url" target="http://bio-bwa.sourceforge.net">http://bio-bwa.sourceforge.net</ref>). Untrimmed reads were aligned allowing a maximum of two sequence mismatches and were discarded where they aligned to the genome more than once. Sequence variants were identified with SAMtools (<ref type="url" target="http://samtools.sourceforge.net">http://samtools.sourceforge.net</ref>) and annotated using Annovar (<ref type="url" target="http://www.openbioinformatics.org">http:// www.openbioinformatics.org</ref>). PolyPhen2 (<ref type="url" target="http://genetics.bwh.harvard.edu/pph2">http://genetics.bwh.harvard.edu/pph2</ref>) and SIFT (<ref type="url" target="http://sift.jcvi.org/">http://sift.jcvi.org/</ref>) were used for the calculation of variant effect.</p><p>Variants were filtered to prioritize novel variants not in dbsnp (or in a list of common mouse variants identified by the pipeline) and predicted to be deleterious to the protein by PolyPhen and/or SIFT. For variant validation, G1 samples were genotyped for the ENU variants identified by the exome sequencing using a competitive, allelespecific dual FRET-based assay, KASP (LGC). For genotyping of G3 offspring and IGL1351 pedigree, primers were designed based on the SNV locus-flanking sequence.</p><p>Plates were read in a FLUOStar Optima (BMG Labtechnologies) plate reader.</p><p>Other mice. Nlrp3 2/2 , Asc 2/2 , and Casp11 2/2 mice on a C57BL/6N background were described previously 1 . Il1b and ATP (Sigma). LPS from S. typhimurium was described previously <ref type="bibr" target="#b35">42,</ref><ref type="bibr" target="#b36">43</ref> . Antibodies used include: mouse caspase-1 (clone 4B4, Genentech), human caspase-1 (Bally-1, AdipoGen), caspase-4 (4B9, Enzo Life Sciences), caspase-5 (4429, Cell Signaling Technology), caspase-11 (clone 17D9, Novus Biologicals), Gsdmd (G7422 anti-Gsdmd aa 126-138, Sigma), IL-1b (GTX74034, GeneTex), NLRP3 (clone Cryo-2, AdipoGen), and Flag epitope (M2, Sigma). Macrophage cultures. Bone marrow cells were differentiated in DMEM supplemented with 10% endotoxin-free fetal bovine serum (Omega Scientific) and 20% M-CSF-conditioned medium for 5-6 days. Adherent BMDMs or thioglycollateelicited peritoneal macrophages were cultured overnight in 96-well plates at 1 3 10 6 cells per ml before being primed for 5-6 h with 1 mg ml 21 Pam3CSK4 in OPTI-MEM (Life Technologies). Primed cells were transfected with 2 mg ml 21 LPS or 5 mg ml 21 lipid A by using 0.25% v/v FuGENE HD (Promega) or 20 mg ml <ref type="bibr" target="#b14">21</ref> Ctb, or electroporated with 2 mg ml 21 LPS by using the 4D-Nucleofector system (Lonza) as described previously <ref type="bibr" target="#b0">7</ref> . Unless specified, FuGENE HD was used for the LPS transfection. The other conditions for inflammasome activations were 5 mM ATP, 100 ng ml <ref type="bibr" target="#b14">21</ref> TcdB, 2 mg ml 21 dsDNA plus 0.1% v/v Lipofectamine 2000 (Life Technologies), 0.5 mg ml 21 flagellin plus 0.25% v/v FuGENE HD, 1 mg ml <ref type="bibr" target="#b14">21</ref> MSU, 500 mg ml 21 CPPD, and 1 mM HLLOMe. Infections with P. aeruginosa (ATCC 27853; multiplicity of infection (MOI) 25), E. coli (ATCC 11775, MOI 30), C. rodentium (ATCC 51116, MOI 20), or S. flexneri (ATCC 9199, MOI 20) were for 1.5 h and then cultures were supplemented with 100 mg ml 21 Gentamycin (Life Technologies). For stimulation with TLR agonists or interferons, BMDMs were cultured with 1 mg ml 21 Pam3CSK4, 5 mg ml 21 polyI:C, 5 mg ml 21 LPS, 2 mg ml 21 R848, 75 ng ml 21 IFN-a, or 500 ng ml <ref type="bibr" target="#b14">21</ref> IFN-c for the indicated periods.</p><p>ELISAs were used to measure IL-1b (Meso Scale Discovery) in culture supernatants. A CytoTox 96 Non-Radioactive Cytotoxicity assay (Promega) measured cell death. For measuring RANTES, Luminex assay (Bio-Rad) was used. Each figure legend shows the number of samples per experiment and number of experiments that were analysed independently. For immunoblotting, cells were lysed with RIPA buffer (50 mM Tris-HCl pH 7.4, 150 mM NaCl, 1 mM EDTA, 13 Complete Protease Inhibitor (Roche), 1% Triton X-100, 0.1% SDS). For cleavage studies (Gsdmd p30, caspase-1 p20, and IL-1b p17), pooled culture supernatants and cell extracts were precipitated with 7.2% trichloroacetic acid plus 0.15% sodium deoxycholate.</p><p>Recombinant proteins. DNA encoding Flag-tagged caspase-11 (residues 2-373) and His6-MBP-tagged murine Gsdmd (residues 2-487) were generated by gene synthesis, and subcloned into a modified version of pAcgp67 (BD Biosciences).</p><p>Transfer vectors were co-transfected with BestBac linearized viral DNA (Expression Systems) into Sf9 cells (Life Technologies) using Transit-IT-Insect transfection reagent (Mirus Bio) to produce recombinant baculovirus. The virus was amplified twice to prepare the stock used for protein expression. Protein was expressed in Tni pro cells (Expression Systems). A 22 l Wave bioreactor was inoculated with Tni pro cells at 1 3 10 6 cells per ml in serum-free ESF921 (Expression Systems). At 48 h post infection, the Tni cells were harvested and frozen at 280 uC. For the purification of Gsdmd, the baculovirus cell pellets were thawed and lysed in lysis buffer (50 mM Tris-HCl pH 8.0, 150 mM NaCl, 20 mM imidazole, 1 mM TCEP plus Protease Inhibitor Cocktail (Roche)). The cell lysate was loaded onto a 3 ml NiNTA column (QIAGEN) pre-equilibrated with buffer A (20 mM Tris pH 8.0, 300 mM NaCl, 20 mM imidazole, 0.5 mM TCEP). The column was washed with 20 column volumes buffer A, then eluted with 5 column volumes of buffer B (20 mM Tris-HCl pH 8.0, 300 mM NaCl, 250 mM imidazole, 0.5 mM TCEP). The elutant was then loaded onto a 5 ml MBP column (GE Healthcare Life Sciences) pre-equilibrated with buffer C (20 mM Tris-HCl pH 7.5, 150 mM NaCl, 10% glycerol, 0.5 mM TCEP). The MBP column was washed with 15 column volumes of buffer C. Gsdmd protein was eluted with buffer C containing 10 mM maltose. To cleave off His-MBP tag, purified His6-MBPtagged Gsdmd was digested with TEV (Sigma). Un-cleaved Gsdmd and TEV enzyme were removed by passing through a 3 ml NiNTA column. For the purification of caspase-11, the baculovirus cell pellets were thawed and lysed in lysis buffer (50 mM Tris-HCl pH 7.5, 150 mM NaCl, 0.5 mM TCEP plus protease inhibitor cocktail) for 1 h. The cell lysate was loaded onto a 4 ml Flag column (Sigma) pre-equilibrated with buffer D (50 mM Tris-HCl pH 7.5, 150 mM NaCl, 10% glycerol, 0.5 mM TCEP). The column was washed with 5 column volumes of buffer C, then 20 column volumes of buffer E (buffer D plus 0.1% TritonX-114) followed with 15 column volumes of Buffer D. Caspase-11 was eluted with buffer F (buffer D plus 0.2 mg ml 21 33Flag peptide (Sigma)). The purified recombinant caspase-11 was then concentrated and further purified by a HiLoad 16/60 Superdex 200 column with buffer G (20 mM Tris-HCl pH 7.5, 150 mM NaCl, 10% glycerol). Purified recombinant caspase-11 and Gsdmd were characterized by SDS-PAGE and mass spectrometry, and stored at 220 uC.</p><p>Recombinant Gsdmd processing assay. Recombinant Gsdmd (4 mM) was incubated in the presence or absence of 2 mM recombinant caspase-11 at 37 uC for 30 min in standard caspase reaction buffer (20 mM PIPES pH 7.2, 10% sucrose, 100 mM NaCl, 0.1% CHAPS, 1 mM EDTA, 10 mM DTT). Samples were then subjected to SDS-page followed by Coomassie blue staining (Expedeon). For Edman degradation analysis, samples were blotted onto a PVDF after SDS-page electrophoresis, and the band corresponding to the Gsdmd protein fragment was subjected to N-terminal sequencing using traditional Edman chemistries <ref type="bibr" target="#b37">44</ref> on a 494HT Procise sequencer (Applied Biosystems) with fast cycles <ref type="bibr" target="#b38">45</ref> .</p><p>Plasmids and transient expression. cDNAs encoding Gsdmd (human and mouse), human caspase-4, and caspase-5 were artificially synthesized with a Flag epitope and subcloned into pcDNA3.1/Zeo(1) (Life Technologies) for transient expression in HEK293T cells, or into pLenti6.3/V5-DEST (Life Technologies) for lentivirus production. Human codon-optimized Cas9 was synthesized and subcloned into pLenti7.3 (Life Technologies). Mutagenesis of cDNAs was performed with a QuikChange site-directed mutagenesis kit (Agilent Technologies). For transient expression, HEK293T cells (ATCC) were cultured overnight in 96-well plates at 1.2 3 10 5 cells per ml, then transfected with 2-10 ng of plasmids by using 0.16 ml Lipofectamine 2000. At 24 h after transfection, cytotoxicity against HEK293T cells was measured by CellTiter-Glo (Promega). For human GSDMD processing, HEK293T cells that stably express human GSDMD were selected using 1 mg ml <ref type="bibr" target="#b14">21</ref> Zeocin (Invivogen) after transfection with human GSDMD plasmid. The stable transfectant cells were transiently transfected with 20 ng of human caspase-4 or -5 plasmids as described above. At 24 h after transfection, cells were lysed with RIPA buffer for immunoblotting. HEK293T cell lines used were regularly tested for mycoplasma. All cell lines used were authenticated by short tandem repeat (STR) profiling, single nucleotide polymorphism (SNP) fingerprinting, and mycoplasma testing. Knockout cell lines. Human EA.hy926 (ATCC) endothelial cells and human THP-1 (ATCC) monocytes were lentivirally transduced with Cas9 and single-cell cloned. gRNAs were transduced into Cas9 1 cloned lines by lentiviral delivery with pLKO.1 vector (Sigma) followed by selection of gRNA-expressing cells by Puromycin (Life Technologies). At 11-14 days post-selection, cells were harvested for experiments. The target sequences of gRNA used are 59-GTTGGCTTCCTGGGCTGCTA for human CD81 (control), 59-GCATGCGAGAATCTCACGC for luciferase (control), 59-GGTGTTTTGGATAACTTGG for CASP4 knockout, 59-GTAGTCCGGA GAGTGGTCC for human GSDMD knockout (gRNA1), and 59-AACCACCAG GCAGTAGGGC for human GSDMD knockout (gRNA2). EA.hy926 cells were transfected with 10 mg ml 21 LPS by 0.5% v/v Lipofectamine 2000 or treated with 100 ng ml 21 APO2L (R&amp;D systems). At 24 h after stimulation, cytotoxicity against EA.hy926 was measured by CellTiter-Glo. THP-1 cells were primed with 0.5 mg ml 21 Pam3CSK4 for 4 h, then plated in 96-well plates at 1 3 10 6 cells per ml with OPTI-MEM containing 0.5 mg ml 21 Pam3CSK4, followed by transfection of 2 mg ml 21 dsDNA with 0.125% v/v Lipofectamine 2000. For LPS electroporation into Pam3CSK4-primed THP-1 cells, the Neon transfection system (Life Technologies) was used with 1 3 10 6 cells plus LPS 0.1 mg per chamber condition. All the cell lines used were regularly tested for mycoplasma. All cell lines used were authenticated by STR profiling, SNP fingerprinting, and mycoplasma testing. Gsdmd reconstitution. Macrophage progenitor cells from Gsdmd 2/25 mice (Extended Data Fig. <ref type="figure">8</ref>) were immortalized by ER-Hoxb8 as described previously <ref type="bibr" target="#b39">46,</ref><ref type="bibr" target="#b40">47</ref> .</p><p>The immortalized macrophage progenitor cells were lentivirally transduced with cDNA encoding either wild-type or D276A mouse Gsdmd using pLenti6.3/V5-DEST vector. Cells were selected in 6.25 mg ml 21 Blasticidin (Invitrogen) and differentiated in M-CSF-containing conditioned media <ref type="bibr" target="#b41">48</ref> . Stimulation of ER-Hoxb8-immortalized macrophages was performed as described above. All Hoxb cell lines used were regularly tested for mycoplasma. Endotoxic shock model. Female mice aged 8-10 weeks were injected intraperitoneally with 54 mg kg 21 LPS (E. coli O111:B4, Sigma) and monitored eight times daily for a total of 6 days. Gsdmd 2/2 mice used (Gsdmd 2/2 6-13 ) are described in Extended Data Fig. <ref type="figure">8</ref>. Statistical analysis was performed with log-rank (Mantel-Cox) tests using Prism, and P values were adjusted to account for multiple comparisons using Bonferroni's correction. Sample sizes were chosen by standard methods to ensure adequate power and no mice were excluded from the analysis. No randomization or blinding was used for the animal studies. No statistical method was used to estimate sample size. The Genentech Institutional Animal Care and Use Committee approved all animal studies.</p><p>Extended Data Figure <ref type="figure" target="#fig_0">1</ref>  </p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>ARTICLE RESEARCH</head><p>G2015 Macmillan Publishers Limited. All rights reserved</p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>Figure 1 |</head><label>1</label><figDesc>Figure 1 | Gsdmd mutation I105N abolishes non-canonical inflammasome signalling. a, Screening of third-generation offspring from ENU-treated C57BL/6 mice. Graphs indicate IL-1b released from peritoneal macrophages cultured for 16 h. Circles indicate Casp11 mutant 129 (black), IGL1351-11 (red), and other G3 offspring (grey). Centre bars represent averages. b, Schematic of mouse Gsdmd. Gasdermin domain is grey (Pfam PF04598). c, d, Immunoblots of wild-type (WT) BMDMs (c) or the genotypes indicated (d) after 6 h culture. e, IL-1b and LDH released from BMDMs after 16 h. Graphs show mean 6 s.d. of triplicate wells and represent three independent experiments. LPS Ctb, LPS plus cholera toxin B complex. For source gels of c and d, see Supplementary Fig. 1.</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head></head><label></label><figDesc>d e n t i u m S . fl e x n e r i P . a e r u g i n o s a F l a g e l l i n d s D N A Cytotoxicity (LDH release (%))</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_2"><head>Figure 2 |</head><label>2</label><figDesc>Figure 2 | Gsdmd is essential for non-canonical inflammasome signalling. a, c, IL-1b and LDH released from BMDMs after 16 h. P. aeruginosa infection was analysed after 4 h. Gsdmd 2/21 and Gsdmd 2/22 are independent knockout strains. b, Immunoblots of pooled cell extracts and supernatants from BMDMs at 6 h after electroporation with LPS. For source gels, see Supplementary Fig. 1. d, Cytotoxicity of APO2L or transfected LPS on control, GSDMD-knockout, or CASP4-knockout EA.hy926 cells after 16 h. Graphs show mean 6 s.d. of triplicate wells and represent three independent experiments. gRNA, singleguide RNA.</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_3"><head>Figure 3 |Figure 4 |</head><label>34</label><figDesc>Figure 3 | Caspase-11 cleaves Gsdmd. a, Immunoblots of BMDM extracts and supernatants at 6 h after LPS electroporation. Non-specific bands are indicated with asterisks. b, Coomassie blue staining of Gsdmd incubated with caspase-11. N terminus of the band marked with an asterisk is shown. c, Cytotoxicity of mouse Gsdmd in HEK293Ts. Numbers indicate nanograms of plasmid transfected. d, IL-1b and LDH released from reconstituted Gsdmd 2/2 immortalized macrophages at 16 h after LPS transfection. e, Immunoblots of immortalized macrophage extracts and supernatants in d. Non-specific band is indicated with an asterisk. Graphs show mean 6 s.d. of triplicate wells and represent three independent experiments. For source gels of a, c, and e, see Supplementary Fig. 1.</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_4"><head>Figure 5 |Figure 6 |</head><label>56</label><figDesc>Figure 5 | Role of Gsdmd in canonical inflammasome signalling. a, b, Immunoblots of BMDM extracts and supernatants after stimulation with ATP for 8 h (a) or as indicated (b). Non-specific band is indicated with an asterisk. For source gels, see Supplementary Fig. 2. c, LDH released from BMDMs after LPS electroporation or the treatments indicated. Gsdmd 2/23 and Gsdmd 2/24 are independent knockout strains. d, Model for canonical inflammasome signalling. Graphs show mean 6 s.d. of triplicate wells and represent three independent experiments.</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_5"><head></head><label></label><figDesc>Fig. 8). c, IL-1b released from BMDMs. LPS, LPS electroporation. Graphs show mean 6 s.d. of triplicate wells and represent three independent experiments. d, Immunoblots of Casp1 2/2 BMDMs stimulated with Pam3CSK4 for 5 h. For source gels of a, b and d, see Supplementary Fig.3.</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0"><head></head><label></label><figDesc></figDesc><graphic coords="11,39.57,57.77,510.46,363.06" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0"><head></head><label></label><figDesc></figDesc><graphic coords="12,44.96,57.77,511.03,372.76" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0"><head></head><label></label><figDesc></figDesc><graphic coords="13,77.27,57.83,435.01,152.96" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0"><head></head><label></label><figDesc></figDesc><graphic coords="14,123.48,57.77,356.83,299.28" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0"><head></head><label></label><figDesc></figDesc><graphic coords="15,108.00,57.77,373.61,245.08" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0"><head></head><label></label><figDesc></figDesc><graphic coords="16,163.56,57.83,273.83,423.50" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0"><head></head><label></label><figDesc></figDesc><graphic coords="17,44.11,69.73,501.45,188.79" type="bitmap" /></figure>
		</body>
		<back>

			<div type="acknowledgement">
<div><p>Acknowledgements We thank the staff of the <rs type="institution" subtype="infrastructure">Australian Phenomics Facility</rs>, <rs type="institution">Genentech Transgenic Technology</rs> and FACS cores, and <rs type="person">K. Bowman</rs>, <rs type="person">J. Payandeh</rs>, <rs type="person">E. Dueber</rs>, <rs type="person">R. Aglietti</rs>, <rs type="person">A. Gupta</rs> and <rs type="person">A. Peterson</rs> for technical expertise and discussion, <rs type="person">K. Newton</rs> for manuscript editing, <rs type="person">A. Muszyn Â´ski</rs>, <rs type="person">L. S. Forsberg</rs>, and <rs type="person">R. W. Carlson</rs> for S. typhimurium LPS. Most authors were employees of <rs type="institution">Genentech, Inc</rs>. Author Contributions N.K., I.B.S., B.L.L., K.O., T.C., B.H., P.S.L., Q.T.P., J.R.L., H.L., J.W., S.K., J.Z., W.P.L., S.J.S., L.X.M., L.F., Y.Z. and E.M.B. designed and performed experiments. K.A. and S.W. generated Gsdmd 2/2 mice. S.W. and M.R.-G. generated Casp1 2/2 mice. N.K. and E.M.B. prepared the manuscript. N.K., G.S.S., E.M.B., C.C.G. and V.M.D. contributed to the study design and data analyses.</p></div>
			</div>
			<listOrg type="infrastructure">
				<org type="infrastructure">					<orgName type="extracted">Australian Phenomics Facility</orgName>
				</org>
			</listOrg>

			<div type="availability">
<div xmlns="http://www.tei-c.org/ns/1.0"><p>Extended Data Table 1 | Bioinformatic analysis of ENU-induced SNVs present in IGL1351 pedigree Ref Base, reference base. Var Base, variant base.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>RESEARCH ARTICLE</head><p>G2015 Macmillan Publishers Limited. All rights reserved</p></div>
			</div>

			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><p>Supplementary Information is available in the online version of the paper.</p><p>Author Information Reprints and permissions information is available at www.nature.com/reprints. The authors declare no competing financial interests. Readers are welcome to comment on the online version of the paper. Correspondence and requests for materials should be addressed to N.K. (kayagaki@gene.com) or V.M.D. (dixit@gene.com).</p><p>Extended Data Table <ref type="table">2</ref> | Adjusted P values of Fig. <ref type="figure">6</ref> ARTICLE RESEARCH G2015 Macmillan Publishers Limited. All rights reserved</p></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">Noncanonical inflammasome activation by intracellular LPS independent of TLR4</title>
		<author>
			<persName><forename type="first">N</forename><surname>Kayagaki</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Science</title>
		<imprint>
			<biblScope unit="volume">341</biblScope>
			<biblScope unit="page" from="1246" to="1249" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">Cytoplasmic LPS activates caspase-11: implications in TLR4-independent endotoxic shock</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Hagar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">A</forename><surname>Powell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Aachoui</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">K</forename><surname>Ernst</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">A</forename><surname>Miao</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Science</title>
		<imprint>
			<biblScope unit="volume">341</biblScope>
			<biblScope unit="page" from="1250" to="1253" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">Inflammatory caspases are innate immune receptors for intracellular LPS</title>
		<author>
			<persName><forename type="first">J</forename><surname>Shi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature</title>
		<imprint>
			<biblScope unit="volume">514</biblScope>
			<biblScope unit="page" from="187" to="192" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">Genome-wide ENU mutagenesis to reveal immune regulators</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">A</forename><surname>Nelms</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">C</forename><surname>Goodnow</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Immunity</title>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="page" from="409" to="418" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">Innate immune sensing of bacterial modifications of Rho GTPases by the Pyrin inflammasome</title>
		<author>
			<persName><forename type="first">H</forename><surname>Xu</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature</title>
		<imprint>
			<biblScope unit="volume">513</biblScope>
			<biblScope unit="page" from="237" to="241" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">Identification and characterization of human DFNA5L, mouse Dfna5l, and rat Dfna5l genes in silico</title>
		<author>
			<persName><forename type="first">M</forename><surname>Katoh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Katoh</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Int. J. Oncol</title>
		<imprint>
			<biblScope unit="volume">25</biblScope>
			<biblScope unit="page" from="765" to="770" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">Gasdermin D (Gsdmd) is dispensable for mouse intestinal epithelium development</title>
		<author>
			<persName><forename type="first">T</forename><surname>Fujii</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Genesis</title>
		<imprint>
			<biblScope unit="volume">46</biblScope>
			<biblScope unit="page" from="418" to="423" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">Members of a novel gene family, Gsdm, are expressed exclusively in the epithelium of the skin and gastrointestinal tract in a highly tissue-specific manner</title>
		<author>
			<persName><forename type="first">M</forename><surname>Tamura</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Genomics</title>
		<imprint>
			<biblScope unit="volume">89</biblScope>
			<biblScope unit="page" from="618" to="629" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">HIN-200 proteins regulate caspase activation in response to foreign cytoplasmic DNA</title>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">L</forename><surname>Roberts</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Science</title>
		<imprint>
			<biblScope unit="volume">323</biblScope>
			<biblScope unit="page" from="1057" to="1060" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">The AIM2 inflammasome is critical for innate immunity to Francisella tularensis</title>
		<author>
			<persName><forename type="first">T</forename><surname>Fernandes-Alnemri</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature Immunol</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="page" from="385" to="393" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">AIM2 recognizes cytosolic dsDNA and forms a caspase-1activating inflammasome with ASC</title>
		<author>
			<persName><forename type="first">V</forename><surname>Hornung</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature</title>
		<imprint>
			<biblScope unit="volume">458</biblScope>
			<biblScope unit="page" from="514" to="518" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">Cytosolic flagellin requires Ipaf for activation of caspase-1 and interleukin 1b in salmonella-infected macrophages</title>
		<author>
			<persName><forename type="first">L</forename><surname>Franchi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature Immunol</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="page" from="576" to="582" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">Listeria monocytogenes-infected human peripheral blood mononuclear cells produce IL-1b, depending on listeriolysin O and NLRP3</title>
		<author>
			<persName><forename type="first">K</forename><surname>Meixenberger</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Immunol</title>
		<imprint>
			<biblScope unit="volume">184</biblScope>
			<biblScope unit="page" from="922" to="930" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">The inflammasomes</title>
		<author>
			<persName><forename type="first">K</forename><surname>Schroder</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Tschopp</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cell</title>
		<imprint>
			<biblScope unit="volume">140</biblScope>
			<biblScope unit="page" from="821" to="832" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">Gout-associated uric acid crystals activate the NALP3 inflammasome</title>
		<author>
			<persName><forename type="first">F</forename><surname>Martinon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Petrilli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Mayor</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Tardivel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Tschopp</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature</title>
		<imprint>
			<biblScope unit="volume">440</biblScope>
			<biblScope unit="page" from="237" to="241" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization</title>
		<author>
			<persName><forename type="first">V</forename><surname>Hornung</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature Immunol</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="page" from="847" to="856" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">Immune recognition of Pseudomonas aeruginosa mediated by the IPAF/NLRC4 inflammasome</title>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">S</forename><surname>Sutterwala</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Exp. Med</title>
		<imprint>
			<biblScope unit="volume">204</biblScope>
			<biblScope unit="page" from="3235" to="3245" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">Human caspase-4 mediates noncanonical inflammasome activation against gram-negative bacterial pathogens</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">N</forename><surname>Casson</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Proc. Natl Acad. Sci. USA</title>
		<imprint>
			<biblScope unit="volume">112</biblScope>
			<biblScope unit="page" from="6688" to="6693" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">Caspases: evolutionary aspects of their functions in vertebrates</title>
		<author>
			<persName><forename type="first">K</forename><surname>Sakamaki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Satou</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Fish Biol</title>
		<imprint>
			<biblScope unit="volume">74</biblScope>
			<biblScope unit="page" from="727" to="753" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">Death receptors: signaling and modulation</title>
		<author>
			<persName><forename type="first">A</forename><surname>Ashkenazi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">M</forename><surname>Dixit</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Science</title>
		<imprint>
			<biblScope unit="volume">281</biblScope>
			<biblScope unit="page" from="1305" to="1308" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">A combinatorial approach defines specificities of members of the caspase family and granzyme B. Functional relationships established for key mediators of apoptosis</title>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">A</forename><surname>Thornberry</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Biol. Chem</title>
		<imprint>
			<biblScope unit="volume">272</biblScope>
			<biblScope unit="page" from="17907" to="17911" />
			<date type="published" when="1997">1997</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">Dual role of caspase-11 in mediating activation of caspase-1 and caspase-3 under pathological conditions</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">J</forename><surname>Kang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Cell Biol</title>
		<imprint>
			<biblScope unit="volume">149</biblScope>
			<biblScope unit="page" from="613" to="622" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main">Necroptosis: the release of damage-associated molecular patterns and its physiological relevance</title>
		<author>
			<persName><forename type="first">A</forename><surname>Kaczmarek</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Vandenabeele</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">V</forename><surname>Krysko</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Immunity</title>
		<imprint>
			<biblScope unit="volume">38</biblScope>
			<biblScope unit="page" from="209" to="223" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main">Caspase-11 activates a canonical NLRP3 inflammasome by promoting K 1 efflux</title>
		<author>
			<persName><forename type="first">S</forename><surname>Ru Â¨hl</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Broz</surname></persName>
		</author>
		<idno type="DOI">10.1002/eji.201545772</idno>
		<ptr target="http://dx.doi.org/10.1002/eji.201545772" />
	</analytic>
	<monogr>
		<title level="j">Eur. J. Immunol</title>
		<imprint>
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main">Inflammatory stimuli regulate caspase substrate profiles</title>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">J</forename><surname>Agard</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Maltby</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Wells</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Mol. Cell. Proteomics</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="page" from="880" to="893" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main">Evolution of inflammasome functions in vertebrates: Inflammasome and caspase-1 trigger fish macrophage cell death but are dispensable for the processing of IL-1b</title>
		<author>
			<persName><forename type="first">D</forename><surname>Angosto</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Innate Immun</title>
		<imprint>
			<biblScope unit="volume">18</biblScope>
			<biblScope unit="page" from="815" to="824" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main">A novel heterodimeric cysteine protease is required for interleukin-1 beta processing in monocytes</title>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">A</forename><surname>Thornberry</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature</title>
		<imprint>
			<biblScope unit="volume">356</biblScope>
			<biblScope unit="page" from="768" to="774" />
			<date type="published" when="1992">1992</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main">Mechanisms of interleukin-1b release</title>
		<author>
			<persName><forename type="first">C</forename><surname>Eder</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Immunobiology</title>
		<imprint>
			<biblScope unit="volume">214</biblScope>
			<biblScope unit="page" from="543" to="553" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main">Single-cell imaging of caspase-1 dynamics reveals an all-or-none inflammasome signaling response</title>
		<author>
			<persName><forename type="first">T</forename><surname>Liu</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cell Rep</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page" from="974" to="982" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main">Murine caspase-11, an ICE-interacting protease, is essential for the activation of ICE</title>
		<author>
			<persName><forename type="first">S</forename><surname>Wang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cell</title>
		<imprint>
			<biblScope unit="volume">92</biblScope>
			<biblScope unit="page" from="501" to="509" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main">Caspase-1-induced pyroptosis is an innate immune effector mechanism against intracellular bacteria</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">A</forename><surname>Miao</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature Immunol</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="page" from="1136" to="1142" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main">Pyroptosis: host cell death and inflammation</title>
		<author>
			<persName><forename type="first">T</forename><surname>Bergsbaken</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">L</forename><surname>Fink</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">T</forename><surname>Cookson</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature Rev. Microbiol</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="page" from="99" to="109" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main">Edwardsiella tarda-induced cytotoxicity depends on its type III secretion system and flagellin</title>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">X</forename><surname>Xie</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Infect. Immun</title>
		<imprint>
			<biblScope unit="volume">82</biblScope>
			<biblScope unit="page" from="3436" to="3445" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main">Caspase-11 controls interleukin-1b release through degradation of TRPC1</title>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">F</forename><surname>Py</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cell Rep</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="page" from="1122" to="1128" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title level="a" type="main">Massively parallel sequencing of the mouse exome to accurately identify rare, induced mutations: an immediate source for thousands of new mouse models</title>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">D</forename><surname>Andrews</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Open Biol</title>
		<imprint>
			<biblScope unit="volume">2</biblScope>
			<biblScope unit="page">120061</biblScope>
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b35">
	<analytic>
		<title level="a" type="main">Lipopolysaccharides in Rhizobium-legume symbioses</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">W</forename><surname>Carlson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">S</forename><surname>Forsberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">L</forename><surname>Kannenberg</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Subcell. Biochem</title>
		<imprint>
			<biblScope unit="volume">53</biblScope>
			<biblScope unit="page" from="339" to="386" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b36">
	<analytic>
		<title level="a" type="main">Identification of cptA, a PmrA-regulated locus required for phosphoethanolamine modification of the Salmonella enterica serovar typhimurium lipopolysaccharide core</title>
		<author>
			<persName><forename type="first">R</forename><surname>Tamayo</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Bacteriol</title>
		<imprint>
			<biblScope unit="volume">187</biblScope>
			<biblScope unit="page" from="3391" to="3399" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b37">
	<analytic>
		<title level="a" type="main">A method for the determination of amino acid sequence in peptides</title>
		<author>
			<persName><forename type="first">P</forename><surname>Edman</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Arch. Biochem</title>
		<imprint>
			<biblScope unit="volume">22</biblScope>
			<biblScope unit="page">475</biblScope>
			<date type="published" when="1949">1949</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b38">
	<analytic>
		<title level="a" type="main">Protein identification using 20-minute Edman cycles and sequence mixture analysis</title>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">J</forename><surname>Henzel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Tropea</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Dupont</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Anal. Biochem</title>
		<imprint>
			<biblScope unit="volume">267</biblScope>
			<biblScope unit="page" from="148" to="160" />
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b39">
	<analytic>
		<title level="a" type="main">Quantitative production of macrophages or neutrophils ex vivo using conditional Hoxb8</title>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">G</forename><surname>Wang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature Methods</title>
		<imprint>
			<biblScope unit="volume">3</biblScope>
			<biblScope unit="page" from="287" to="293" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b40">
	<analytic>
		<title level="a" type="main">Phosphorylation of NLRC4 is critical for inflammasome activation</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Qu</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature</title>
		<imprint>
			<biblScope unit="volume">490</biblScope>
			<biblScope unit="page" from="539" to="542" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b41">
	<analytic>
		<title level="a" type="main">Hoxb8 conditionally immortalised macrophage lines model inflammatory monocytic cells with important similarity to dendritic cells</title>
		<author>
			<persName><forename type="first">M</forename><surname>Rosas</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Eur. J. Immunol</title>
		<imprint>
			<biblScope unit="volume">41</biblScope>
			<biblScope unit="page" from="356" to="365" />
			<date type="published" when="2011">2011</date>
			<publisher>Macmillan Publishers Limited. All rights reserved</publisher>
		</imprint>
	</monogr>
	<note>ARTICLE RESEARCH G2015</note>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
